Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP32 activates resistance GC cells cisplatin. 1 / 1

| 1

➶

eidos

"Furthermore , knockdown of USP32 attenuated the resistance of GC cells to cisplatin in CCK8 assays , whereas overexpression of SMAD2 partially rescued the defect of USP32 silenced GC cells in cisplatin resistance ( Figure 6B ) , suggesting that USP32 may confer chemoresistance in GC ."

32226309

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...